SCHEMBL23558442

SCHEMBL23558442

O=C1CC(CO)(CO)Oc2ccc(-c3cc(-c4ccncc4)no3)cc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ S1PR1 P21453 1/20 0.42
▸ ABCB1 P08183 1/20 0.38
▸ ABCC1 P33527 1/20 0.38
▸ CYP1A2 P05177 3/20 0.37
▸ CYP2C9 P11712 3/20 0.37
▸ CYP2C19 P33261 3/20 0.37
▸ CYP3A4 P08684 2/20 0.37
▸ CYP2D6 P10635 2/20 0.37
▸ EPHX2 P34913 1/20 0.36
▸ HSD17B1 P14061 1/20 0.35
▸ HSD17B2 P37059 1/20 0.35
▸ MAPT P10636 1/20 0.33
▸ NPC1 O15118 5/20 0.33
▸ RAB9A P51151 5/20 0.33
▸ MAOB P27338 3/20 0.32
▸ MAOA P21397 1/20 0.32
▸ RARA P10276 1/20 0.32
▸ RARB P10826 1/20 0.32
▸ RARG P13631 1/20 0.32
▸ RXRA P19793 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23558568 0.90 HSD17B1 (0.46) ABCB1ABCC1CYP1A2CYP2C9CYP2C19
SCHEMBL23558433 0.85 HSD17B1 (0.51) ABCB1ABCC1HSD17B1HSD17B2MAPT
SCHEMBL23558496 0.84 S1PR1 (0.35) S1PR1ABCB1ABCC1CYP1A2CYP2C9
SCHEMBL23558481 0.83 RAB9A (0.42) ABCB1ABCC1CYP1A2CYP2C9CYP2C19
SCHEMBL23524238 0.83 NPC1 (0.44) S1PR1MAPTNPC1RAB9AMEN1
SCHEMBL23558404 0.83 ABCB1 (0.51) S1PR1ABCB1ABCC1NPC1RAB9A
SCHEMBL23558589 0.82 NPC1 (0.33) ABCB1ABCC1CYP1A2CYP2C9CYP2C19
SCHEMBL23558461 0.80 NPC1 (0.45) ABCB1ABCC1CYP1A2CYP2C9CYP2C19
SCHEMBL23558330 0.78 RAB9A (0.40) ABCB1ABCC1CYP1A2CYP2C9CYP2C19
SCHEMBL25856889 0.77 CYP2C9 (0.41) S1PR1CYP1A2CYP2C9CYP2C19CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210188826-A1 COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME TREVENA, INC. 2021-06-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210188826-A1 COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME S1PR1, S1PR2, S1PR3 S1PR1 1/4885ABCB1 3052/4885ABCC1 2927/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback